AU
UK
CA
NZ
IND
US
Exagen Inc. (Nasdaq: XGN) surged 35 per cent to close at $3.98 on Tuesday after the medical diagnostics company reported a first quarter that exceeded expectations on the metrics that matter most for a diagnosticsBusinessat this stage of its commercial development: volume, pricing, and …
Liquidia Corporation (Nasdaq: LQDA) delivered one of the most emphatic commercial readouts in the pulmonary hypertension space on Tuesday, sending its shares 25 per cent higher to close at $53.13 as investors digested a first-quarter performance that left little room for equivocation. YUTREPIA, the …
Actuate Therapeutics (Nasdaq: ACTU) closed 10 per cent lower at $2.98 on Tuesday, in what may rank as one of the more counterintuitive market reactions of the session. The company had just announced that the US Food and Drug Administration had cleared its Investigational …
Aditxt, Inc. (NASDAQ: ADTX) closed 8 per cent lower at $0.11 on Tuesday as shareholders absorbed the implications of a Nasdaq Staff Determination letter that brought the company to the edge of a potentially terminal regulatory cliff. The disclosure confirmed what the share price …
Shares in Ensysce Biosciences (Nasdaq: ENSC) closed 9 per cent higher at $0.38 on Tuesday, as the company placed itself at the centre of one of the most consequential debates in contemporary pharmacology: how to engineer effective pain relief without handing patients or recreational …
Introduction
The Return Nobody Expected
A Structural Contest, Not a Crisis
From Oil Markets to Farm Fields: How the Iran Conflict Is ReshapingCommodityPositioning
Please wait processing your request...